Skip to content

Chengdu Kanghua Biological Products Co Ltd Sustainability Reports

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, and sale of biological products and vaccines for human use in China. Its main products include freeze-dried human rabies vaccines and meningococcal polysaccharide vaccines.

Sector: Manufacturing

Country: China

Exchange: Shenzhen Stock Exchange

FIGI: BBG00MZ2NKK6

2 reports from 2023 to 2024